Home > Insider Trading > Filing (0000899243-22-001807)

Filing Details

Accession Number:: 0000899243-22-001807
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-01-12 19:30:12
Reporting Period:: 2022-01-10

Accepted Time:: 2022-01-12 19:30:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1815442	Kymera Therapeutics Inc.	KYMR	Biological Products, (No Disgnostic Substances) (2836)	812992166

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1821189	Nello Mainolfi	C/O Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-01-10	22,465	$2.08	494,664	No	4	M	Direct
Common Stock	Disposition	2022-01-10	7,485	$52.46	487,179	No	4	S	Direct
Common Stock	Disposition	2022-01-10	10,673	$53.35	476,506	No	4	S	Direct
Common Stock	Disposition	2022-01-10	4,201	$54.40	472,305	No	4	S	Direct
Common Stock	Disposition	2022-01-10	106	$54.99	472,199	No	4	S	Direct
Common Stock	Acquisiton	2022-01-11	16,923	$2.08	489,122	No	4	M	Direct
Common Stock	Disposition	2022-01-11	9,932	$53.68	479,190	No	4	S	Direct
Common Stock	Disposition	2022-01-11	6,644	$54.42	472,546	No	4	S	Direct
Common Stock	Disposition	2022-01-11	347	$55.05	472,199	No	4	S	Direct
Common Stock	Acquisiton	2022-01-12	8,612	$2.08	480,811	No	4	M	Direct
Common Stock	Disposition	2022-01-12	2,726	$51.31	478,085	No	4	S	Direct
Common Stock	Disposition	2022-01-12	4,022	$52.02	474,063	No	4	S	Direct
Common Stock	Disposition	2022-01-12	1,623	$53.27	472,440	No	4	S	Direct
Common Stock	Disposition	2022-01-12	241	$53.97	472,199	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-01-10	22,465	$0.00	22,465	$2.08
Common Stock	Stock Option (Right to Buy)	Disposition	2022-01-11	16,923	$0.00	16,923	$2.08
Common Stock	Stock Option (Right to Buy)	Disposition	2022-01-12	8,612	$0.00	8,612	$2.08

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
599,815	2029-11-13	No	4	M	Direct
582,892	2029-11-13	No	4	M	Direct
574,280	2029-11-13	No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.99 to $52.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.99 to $53.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.99 to $54.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.01 to $54.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.01 to $54.995. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.05 to $55.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.60 to $51.575. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $52.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.88 to $53.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date.